Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · IEX Real-Time Price · USD
4.100
-0.130 (-3.07%)
At close: Apr 18, 2024, 3:53 PM
4.000
-0.100 (-2.44%)
After-hours: Apr 18, 2024, 4:32 PM EDT

Marker Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2012
Revenue
3.313.511.240.470.210.210.18000
Upgrade
Revenue Growth (YoY)
-5.76%182.96%166.01%118.95%3.50%12.53%----
Upgrade
Gross Profit
3.313.511.240.470.210.210.18000
Upgrade
Selling, General & Admin
7.4811.3412.9210.479.9824.386.414.694.453.18
Upgrade
Research & Development
10.4211.9727.7918.8812.761245.253.81.710.19
Upgrade
Operating Expenses
17.8923.340.7229.3522.74148.3811.668.496.163.37
Upgrade
Operating Income
-14.58-19.79-39.48-28.89-22.53-148.17-11.48-8.49-6.16-3.37
Upgrade
Interest Expense / Income
000000000.010.08
Upgrade
Other Expense / Income
-6.3510.142.4-0.18-1.1-0.21-0.5-6.0427.927.43
Upgrade
Pretax Income
-8.23-29.93-41.88-28.71-21.43-147.96-10.98-2.46-34.07-30.88
Upgrade
Income Tax
0000000000
Upgrade
Net Income
-8.24-29.93-41.88-28.71-21.43-147.96-10.98-2.46-34.07-30.88
Upgrade
Shares Outstanding (Basic)
9885521100
Upgrade
Shares Outstanding (Diluted)
9885521100
Upgrade
Shares Change
5.49%9.16%62.64%3.19%138.78%101.96%27.39%102.63%184.17%1261.19%
Upgrade
EPS (Basic)
-0.94-3.58-5.47-6.10-4.70-77.50-11.60-3.60-93.00-240.00
Upgrade
EPS (Diluted)
-0.94-3.58-5.47-6.10-4.70-77.50-11.60-7.20-93.00-240.00
Upgrade
Free Cash Flow
-16.44-26.97-30.41-29.29-18.66-14.63-8.44-6.51-4.34-2.19
Upgrade
Free Cash Flow Per Share
-1.87-3.23-3.98-6.23-4.09-7.66-8.93-9.45-11.86-16.97
Upgrade
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%100.00%---
Upgrade
Operating Margin
-440.37%-563.28%-3179.32%-6188.25%-10567.28%-71930.07%-6271.05%---
Upgrade
Profit Margin
-248.76%-851.87%-3372.68%-6149.74%-10050.92%-71826.32%-5999.09%---
Upgrade
Free Cash Flow Margin
-496.51%-767.66%-2449.11%-6274.32%-8752.25%-7100.98%-4610.10%---
Upgrade
EBITDA
-8.23-29.93-38.72-27.63-21.14-147.96-10.98-2.46-34.06-30.8
Upgrade
EBITDA Margin
-248.65%-851.87%-3117.98%-5919.30%-9916.50%-71826.32%-5999.09%---
Upgrade
Depreciation & Amortization
003.161.080.2900000
Upgrade
EBIT
-8.23-29.93-41.88-28.71-21.43-147.96-10.98-2.46-34.06-30.8
Upgrade
EBIT Margin
-248.65%-851.87%-3372.68%-6149.74%-10050.92%-71826.32%-5999.09%---
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).